Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitorsComparative Study Published on 2023-04-012023-06-12 Journal: Hepatology international [Category] B형 간염, [키워드] antiviral therapy hepatitis B surface antigen Hepatitis B virus Hepatocellular carcinoma Immunotherapy Median survival time Prognosis Programmed cell death protein-1 inhibitor Reactivation tyrosine kinase inhibitor [DOI] 10.1007/s12072-022-10450-4 [Article Type] Comparative Study
Risk of hepatitis B reactivation in HBsAg-/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta-analysisReview Published on 2023-02-012023-06-12 Journal: Immunity, Inflammation and Disease [Category] B형 간염, [키워드] Biologic therapy Hepatitis B virus Reactivation rheumatoid arthritis [DOI] 10.1002/iid3.780 PMC 바로가기 [Article Type] Review
Varicella Zoster Virus Neuronal Latency and Reactivation Modeled in VitroReview Published on 2023-01-012023-05-31 Journal: Current Topics in Microbiology and Immunology [Category] 두창, 수두, 홍역, [키워드] latency Reactivation Stem cell-derived human neurons Varicella zoster virus [DOI] 10.1007/82_2021_244 [Article Type] Review
Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian maleCase Reports Published on 2023-01-012023-05-31 Journal: European Journal of Ophthalmology [Category] SARS, 두창, 수두, 홍역, [키워드] Acute retinal necrosis COVID-19 vaccination Reactivation RT-PCR Varicella zoster virus [DOI] 10.1177/11206721211046485 [Article Type] Case Reports
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndromeArticle Published on 2022-10-202022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] analyzed Anti-viral anti-viral antibody antibody Antibody Response baseline chronic disease CMV cohorts COVID-19 EBV elevated fatigue healthy donor herpesvirus herpesvirus reactivation HERV HERV-K HHV6A HSV2 IgG immunoassay latent virus majority ME/CFS mechanisms multiplex Myalgic encephalomyelitis/chronic fatigue syndrome nuclear oral mucosa overlap Patient plasma Post-viral fatigue Reactivation retrovirus risk factor Saliva SARS-COV-2 infection shown significantly sustained Symptom syndrome systemically triggered unique viral infection virus [DOI] 10.3389/fimmu.2022.949787 PMC 바로가기
Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study헤르페스 바이러스 감염 및 코로나19 이후 발현: 파일럿 관찰 연구Observational Study Published on 2022-09-012022-09-11 Journal: Rheumatology International [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] abnormality accompanied Activation An autoimmune disease Autoimmune Autoimmune disease Cellular immune response clinical and laboratory features CMV complicate contributing to control group controls Course COVID-19 CRP D-dimer detectable Diseases disorders DNA EBV elevated Epstein–Barr virus exaggerate female Fever headache Herpe herpes Herpes virus herpes viruses herpesvirus herpesviruses high mortality high risk Immunocompromised Infection infections laboratory feature liver enzymes male manifestation median age myalgia Numerous Pathologies Patient Reactivation recruited reported rheumatology SARS-CoV-2 severe COVID-19 Spread subject suppressed syndrome temperature the disease Variation variety virus virus infection [DOI] 10.1007/s00296-022-05146-9 PMC 바로가기 [Article Type] Observational Study
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients심각한 COVID-19-Epiphenomena에서 EBV 및 CMV의 재활성화 또는 치료가 필요한 Hyperinflammation의 트리거? 중환자의 대규모 사례 시리즈Article Published on 2022-09-012022-09-11 Journal: Journal of Intensive Care Medicine [Category] 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed ARDS Chain Reaction Characteristics Clinical deterioration CMV cohort study comparable connection control group coronavirus Corticosteroid Course COVID-19 Critically ill Critically ill patient critically ill patients cytomegalovirus decrease described Diagnosis disease EBV Epstein-Barr virus Follow-up analysis Ganciclovir high risk hyperinflammation ICU in viral incidence increased mortality initiation of treatment intensive care intensive care unit majority Non-COVID-19 non-COVID-19 patient Non-COVID-19 patients outcome Patient polymerase chain polymerase chain reaction Reactivation remains uncertain retrospective rituximab SARS-CoV-2 screened Sepsis sepsis patient Sery severe acute respiratory syndrome Coronavirus severe COVID-19 single-center survived systemic corticosteroid treated Treatment Trigger Viral load viral reactivation virus with COVID-19 [DOI] 10.1177/08850666211053990 PMC 바로가기 [Article Type] Article
Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearanceComment Published on 2022-09-012023-07-09 Journal: The Journal of Infection [Category] COVID19(2023년), [키워드] paediatric Reactivation SARS-CoV-2 transplantation [DOI] 10.1016/j.jinf.2022.05.043 PMC 바로가기 [Article Type] Comment
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks PosttreatmentArticle Published on 2022-08-312023-06-13 Journal: Clinical Infectious Diseases: An Official Publicat [Category] B형 간염, Fulltext, [키워드] alanine aminotransferase Coinfection hepatitis B surface antigen Reactivation [DOI] 10.1093/cid/ciab971 PMC 바로가기
Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 PatientsArticle Published on 2022-08-252022-11-15 Journal: Viruses [Category] 치료기술, [키워드] Activation association Autoimmune disorders blood donor Characteristics Coagulopathies Cohort cohorts complex contribute COVID-19 COVID-19 patient detectable disease EBV Epstein-Barr virus Epstein–Barr virus feature fraction Frequency healthy healthy control herpesvirus HHV-6 Hospitalization Hospitalized Human Human Herpesvirus-6 hyperinflammatory responses Infection Inflammation Inflammatory inflammatory disease Inflammatory mediators marker occurred Pathogenesis Patient patients plasma pulmonary disease quantitative PCR Reactivation reported SARS-CoV-2 subset syndrome tested virus with COVID-19 [DOI] 10.3390/v14091872 PMC 바로가기